Introduction Semaglutide has emerged as a groundbreaking medication in the treatment of type 2 diabetes and obesity, with its ability to address multiple health issues through a single solution. Initially developed as a therapy for diabetes, Semaglutide belongs to the GLP-1 (glucagon-like peptide-1) receptor agonists, a class of drugs that https://finnbimqv.dekaronwiki.com/1096868/semaglutide_a_breakthrough_medication_for_weight_loss_diabetes_and_heart_health